JMI Syringes & Medical Devices (DHA:JMISMDL) Selling, General, & Admin. Expense: BDT114 Mil (TTM As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:JMISMDL JMI Syringes & Medical Devices Ltd DHA:JMISMDL
75 GF Score
Price BDT146.50
View Full Analysis

What is JMI Syringes & Medical Devices Selling, General, & Admin. Expense?

JMI Syringes & Medical Devices DHA:JMISMDL +0.55% 75 Selling, General, & Admin. Expense is BDT114 Mil as of Mar. 2025. GuruFocus rates DHA:JMISMDL with a GF Score™ of 75/100.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. JMI Syringes & Medical Devices's selling, general, & admin. expense for the three months ended in Mar. 2025 was BDT28 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2025 was BDT114 Mil.


JMI Syringes & Medical Devices  (DHA:JMISMDL) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


JMI Syringes & Medical Devices Selling, General, & Admin. Expense Related Terms


JMI Syringes & Medical Devices Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for JMI Syringes & Medical Devices's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JMI Syringes & Medical Devices Selling, General, & Admin. Expense Chart

JMI Syringes & Medical Devices Annual Data
Trend Dec15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73.06 72.14 91.86 67.36 75.78

JMI Syringes & Medical Devices Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.14 30.45 17.96 37.54 27.76

DHA:JMISMDL vs ISRG, BDX, MDLN: Selling, General, & Admin. Expense Comparison

For the Medical Instruments & Supplies subindustry, JMI Syringes & Medical Devices's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JMI Syringes & Medical Devices Selling, General, & Admin. Expense vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, JMI Syringes & Medical Devices's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where JMI Syringes & Medical Devices's Selling, General, & Admin. Expense falls into.


DHA:JMISMDL
75GF Score
JMI Syringes & Medical Devices Ltd DHA:JMISMDL
Selling, General, & Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JMI Syringes & Medical Devices Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT114 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling, General, & Admin. Expense of BDT114 Mil mean?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a Selling, General, & Admin. Expense of BDT114 Mil as of Mar. 2025. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on JMI Syringes & Medical Devices and its competitors.
Is JMI Syringes & Medical Devices' Selling, General, & Admin. Expense too high?
JMI Syringes & Medical Devices' current Selling, General, & Admin. Expense is BDT114 Mil. Overall, JMI Syringes & Medical Devices has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does JMI Syringes & Medical Devices' Selling, General, & Admin. Expense compare to ISRG and BDX?
JMI Syringes & Medical Devices' Selling, General, & Admin. Expense of BDT114 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Medical Devices & Instruments company?
A good Selling, General, & Admin. Expense depends on the Medical Devices & Instruments industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on JMI Syringes & Medical Devices and its competitors. JMI Syringes & Medical Devices's current Selling, General, & Admin. Expense is BDT114 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMI Syringes & Medical Devices stock overvalued right now?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a current Selling, General, & Admin. Expense of BDT114 Mil. The current Selling, General, & Admin. Expense is BDT114 Mil. JMI Syringes & Medical Devices' overall GF Score™ is 75/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For JMI Syringes & Medical Devices (DHA:JMISMDL), the current Selling, General, & Admin. Expense is BDT114 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

JMI Syringes & Medical Devices Business Description

Address 117, Kazi Nazrul Islam Avenue, Unique Heights, Level-11, Ramna, Dhaka, BGD, 1217
JMI Syringes & Medical Devices Ltd is a Bangladesh-based syringe and medical device manufacturing company. It manufactures and markets disposable syringe, auto-disable syringe, needle, infusion set, scalp vein set, urine drainage bag, insulin syringe, First AID bandage, riles tube, IV Cannula, feeding tube, and Blood Lancets, and other products.
75GF Score

Get the complete analysis for DHA:JMISMDL

Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT146.50
Price